Biomet Looks Abroad For Revenue Growth In Fiscal 2008
This article was originally published in The Gray Sheet
Executive Summary
Biomet is highlighting growth overseas as a key driver of corporate revenues, and hip and knee reconstruction device sales in particular, reporting 16% top-line expansion for its fiscal fourth quarter (ended May 31)